Noninvasive imaging of reporter gene expression and distribution in vivo

Fooyin Journal of Health Sciences

Volumn 2, Issue 1, 2010, Pages 1-11

  Chuang, Kuo Hsiang ^a   Cheng, Tian Lu ^a  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Endogenous reporter; Exogenous reporter; Noninvasive imaging; Reporter gene

Indexed keywords

BETA GLUCURONIDASE; DOPAMINE 2 RECEPTOR; GREEN FLUORESCENT PROTEIN; LUCIFERASE; RED FLUORESCENT PROTEIN; SODIUM IODIDE SYMPORTER; THYMIDINE KINASE; TRANSFERRIN RECEPTOR; YELLOW FLUORESCENT PROTEIN;

BIOLUMINESCENCE; GENE EXPRESSION PROFILING; HERPES SIMPLEX VIRUS 1; HUMAN; IMMUNOGENICITY; MOLECULAR IMAGING; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REPORTER GENE; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TRANSGENICS;

EID: 77955246880     PISSN: 18778607     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1877-8607(10)60007-0     Document Type: Review

References (77)

1. Tjuvajev JG, Doubrovin M, Akhurst T, et al. Comparison of radiolabeled nucleoside probes (FIAU, FHBG, and FHPG) for PET imaging of HSV1-tk gene expression. J Nucl Med 2002, 43:1072-1083.
2. Tjuvajev JG, Avril N, Oku T, et al. Imaging herpes virus thymidine kinase gene transfer and expression by positron emission tomography. Cancer Res 1998, 58:4333-4341.
3. 18F]FFEAU, and other imaging probes. J Nucl Med 2008, 49:637-648.
4. Elion GB Acyclovir: discovery, mechanism of action, and selectivity. J Med Virol 1993, (Suppl 1):2-6.
5. Alrabiah FA, Sacks SL New antiherpesvirus agents: their targets and therapeutic potential. Drugs 1996, 52:17-32.
6. Tjuvajev JG, Stockhammer G, Desai R, et al. Imaging the expression of transfected genes in vivo. Cancer Res 1995, 55:6126-6132.
7. 2 receptor as a reporter gene in living animals. Gene Ther 1999, 6:785-791.
8. Tai JH, Nguyen B, Wells RG, et al. Imaging of gene expression in live pancreatic islet cell lines using dual-isotope SPECT. J Nucl Med 2008, 49:94-102.
9. Tseng JC, Zanzonico PB, Levin B, et al. Tumor-specific in vivo transfection with HSV-1 thymidine kinase gene using a Sindbis viral vector as a basis for prodrug ganciclovir activation and PET. J Nucl Med 2006, 47:1136-1143.
10. Madsen MT, Park CH Enhancement of SPECT images by Fourier filtering the projection image set. J Nucl Med 1985, 26:395-402.
11. Yeung HW, Macapinlac H, Karpeh M, et al. Accuracy of FDGPET in gastric cancer: preliminary experience. Clin Positron Imaging 1998, 1:213-221.
12. Weissleder R, Ntziachristos V Shedding light onto live molecular targets. Nat Med 2003, 9:123-128.
13. Chuang KH, Wang HE, Cheng TC, et al. Development of a universal anti-polyethylene glycol reporter gene for noninvasive imaging of PEGylated probes. J Nucl Med 2010, 51:933-941.
14. Gambhir SS, Barrio JR, Phelps ME, et al. Imaging adenoviral-directed reporter gene expression in living animals with positron emission tomography. Proc Natl Acad Sci USA 1999, 96:2333-2338.
15. Wang J, Su C, Neuhard J, et al. Expression of human mitochondrial thymidine kinase in Escherichia coli: correlation between the enzymatic activity of pyrimidine nucleoside analogues and their inhibitory effect on bacterial growth. Biochem Pharmacol 2000, 59:1583-1588.
16. Sundaresan G, Paulmurugan R, Berger F, et al. MicroPET imaging of Cre-loxP-mediated conditional activation of a herpes simplex virus type 1 thymidine kinase reporter gene. Gene Ther 2004, 11:609-618.
17. Green LA, Yap CS, Nguyen K, et al. Indirect monitoring of endogenous gene expression by positron emission tomography (PET) imaging of reporter gene expression in transgenic mice. Mol Imaging Biol 2002, 4:71-81.
18. Gambhir SS, Bauer E, Black ME, et al. A mutant herpes simplex virus type 1 thymidine kinase reporter gene shows improved sensitivity for imaging reporter gene expression with positron emission tomography. Proc Natl Acad Sci USA 2000, 97:2785-2790.
19. Yaghoubi SS, Couto MA, Chen CC, et al. Preclinical safety evaluation of 18F-FHBG: a PET reporter probe for imaging herpes simplex virus type 1 thymidine kinase (HSV1-tk) or mutant HSV1-sr39tk's expression. J Nucl Med 2006, 47:706-715.
20. Herschman HR Noninvasive imaging of reporter gene expression in living subjects. Adv Cancer Res 2004, 92:29-80.
21. Johnson AA, Ray AS, Hanes J, et al. Toxicity of antiviral nucleoside analogs and the human mitochondrial DNA polymerase. J Biol Chem 2001, 276:40847-40857.
22. Bonini C, Ferrari G, Verzeletti S, et al. HSV-TK gene transfer into donor lymphocytes for control of allogeneic graftversus-leukemia. Science 1997, 276:1719-1724.
23. Ponomarev V, Doubrovin M, Shavrin A, et al. A human-derived reporter gene for noninvasive imaging in humans: mitochondrial thymidine kinase type 2. J Nucl Med 2007, 48:819-826.
24. Hoffman RM In vivo imaging with fluorescent proteins: the new cell biology. Acta Histochem 2004, 106:77-87.
25. Shimomura O The discovery of aequorin and green fluorescent protein. J Microsc 2005, 217:1-15.
26. Carter RW, Schmale MC, Gibbs PD Cloning of anthozoan fluorescent protein genes. Comp Biochem Physiol C Toxicol Pharmacol 2004, 138:259-270.
27. Yang M, Li L, Jiang P, et al. Dual-color fluorescence imaging distinguishes tumor cells from induced host angiogenic vessels and stromal cells. Proc Natl Acad Sci USA 2003, 100:14259-14262.
28. Troy T, Jekic-McMullen D, Sambucetti L, et al. Quantitative comparison of the sensitivity of detection of fluorescent and bioluminescent reporters in animal models. Mol Imaging 2004, 3:9-23.
29. Gambotto A, Dworacki G, Cicinnati V, et al. Immunogenicity of enhanced green fluorescent protein (EGFP) in BALB/c mice: identification of an H2-Kd-restricted CTL epitope. Gene Ther 2000, 7:2036-2040.
30. Gross S, Piwnica-Worms D Spying on cancer: molecular imaging in vivo with genetically encoded reporters. Cancer Cell 2005, 7:5-15.
31. Yu YA, Timiryasova T, Zhang Q, et al. Optical imaging: bacteria, viruses, and mammalian cells encoding light-emitting proteins reveal the locations of primary tumors and metastases in animals. Anal Bioanal Chem 2003, 377:964-972.
32. Serganova I, Blasberg R Reporter gene imaging: potential impact on therapy. Nucl Med Biol 2005, 32:763-780.
33. Wu JC, Chen IY, Sundaresan G, et al. Molecular imaging of cardiac cell transplantation in living animals using optical bioluminescence and positron emission tomography. Circulation 2003, 108:1302-1305.
34. Iyer M, Sato M, Johnson M, et al. Applications of molecular imaging in cancer gene therapy. Curr Gene Ther 2005, 5:607-618.
35. Lorenz WW, McCann RO, Longiaru M, et al. Isolation and expression of a cDNA encoding Renilla reniformis luciferase. Proc Natl Acad Sci U S A 1991, 88:4438-4442.
36. Bergwerf I, De Vocht N, Tambuyzer B, et al. Reporter gene-expressing bone marrow-derived stromal cells are immune-tolerated following implantation in the central nervous system of syngeneic immunocompetent mice. BMC Biotechnol 2009, 9:1.
37. 2 receptor reporter gene in which ligand binding is uncoupled from signal transduction. Gene Ther 2001, 8:1490-1498.
38. Wolf G Vitamin A functions in the regulation of the dopaminergic system in the brain and pituitary gland. Nutr Rev 1998, 56:354-355.
39. Weissleder R, Moore A, Mahmood U, et al. In vivo magnetic resonance imaging of transgene expression. Nat Med 2000, 6:351-355.
40. Basilion JP, Kennedy MC, Beinert H, et al. Overexpression of iron-responsive element-binding protein and its analytical characterization as the RNA-binding form, devoid of an iron-sulfur cluster. Arch Biochem Biophys 1994, 311:517-522.
41. Barth BM, Sharma R, Altinoglu EI, et al. Bioconjugation of calcium phosphosilicate composite nanoparticles for selective targeting of human breast and pancreatic cancers in vivo. ACS Nano 2010, 4:1279-1287.
42. Habashy HO, Powe DG, Staka CM, et al. Transferrin receptor (CD71) is a marker of poor prognosis in breast cancer and can predict response to tamoxifen. Breast Cancer Res Treat 2010, 119:283-293.
43. Fleming RE, Migas MC, Holden CC, et al. Transferrin receptor 2: continued expression in mouse liver in the face of iron overload and in hereditary hemochromatosis. Proc Natl Acad Sci USA 2000, 97:2214-2219.
44. Chung JK Sodium iodide symporter: its role in nuclear medicine. J Nucl Med 2002, 43:1188-1200.
45. Shin JH, Chung JK, Kang JH, et al. Feasibility of sodium/iodide symporter gene as a new imaging reporter gene: comparison with HSV1-tk. Eur J Nucl Med Mol Imaging 2004, 31:425-432.
46. Van Sande J, Massart C, Beauwens R, et al. Anion selectivity by the sodium iodide symporter. Endocrinology 2003, 144:247-252.
47. Cho JY, Shen DH, Yang W, et al. In vivo imaging and radioiodine therapy following sodium iodide symporter gene transfer in animal model of intracerebral gliomas. Gene Ther 2002, 9:1139-1145.
48. Groot-Wassink T, Aboagye EO, Wang Y, et al. Quantitative imaging of Na/I symporter transgene expression using positron emission tomography in the living animal. Mol Ther 2004, 9:436-442.
49. 211At]astatide in NIS-transfected human cancer cells. Nucl Med Biol 2002, 29:729-739.
50. Selmi-Ruby S, Watrin C, Trouttet-Masson S, et al. The porcine sodium/iodide symporter gene exhibits an uncommon expression pattern related to the use of alternative splice sites not present in the human or murine species. Endocrinology 2003, 144:1074-1085.
51. Tazebay UH, Wapnir IL, Levy O, et al. The mammary gland iodide transporter is expressed during lactation and in breast cancer. Nat Med 2000, 6:871-878.
52. Spitzweg C, Joba W, Eisenmenger W, et al. Analysis of human sodium iodide symporter gene expression in extrathyroidal tissues and cloning of its complementary deoxyribonucleic acids from salivary gland, mammary gland, and gastric mucosa. J Clin Endocrinol Metab 1998, 83:1746-1751.
53. Chen KC, Cheng TL, Leu YL, et al. Membrane-localized activation of glucuronide prodrugs by b-glucuronidase enzymes. Cancer Gene Ther 2007, 14:187-200.
54. Chuang KH, Cheng CM, Roffler SR, et al. Combination cancer therapy by hapten-targeted prodrug-activating enzymes and cytokines. Bioconjug Chem 2006, 17:707-714.
55. Haisma HJ, van Muijen M, Pinedo HM, et al. Comparison of two anthracycline-based prodrugs for activation by a monoclonal antibody-b-glucuronidase conjugate in the specific treatment of cancer. Cell Biophys 1994, 24-25:185-192.
56. Houba PH, Boven E, van der Meulen-Muileman IH, et al. A novel doxorubicin-glucuronide prodrug DOX-GA3 for tumour-selective chemotherapy: distribution and efficacy in experimental human ovarian cancer. Br J Cancer 2001, 84:550-557.
57. Schmidt F, Monneret C Prodrug mono therapy: synthesis and biological evaluation of an etoposide glucuronide-prodrug. Bioorg Med Chem 2003, 11:2277-2283.
58. Leu YL, Roffler SR, Chern JW Design and synthesis of water-soluble glucuronide derivatives of camptothecin for cancer prodrug monotherapy and antibody-directed enzyme prodrug therapy (ADEPT). J Med Chem 1999, 42:3623-3628.
59. de Bont DB, Leenders RG, Haisma HJ, et al. Synthesis and biological activity of b-glucuronyl carbamate-based prodrugs of paclitaxel as potential candidates for ADEPT. Bioorg Med Chem 1997, 5:405-414.
60. Bouvier E, Thirot S, Schmidt F, et al. First enzymatically activated Taxotere prodrugs designed for ADEPT and PMT. Bioorg Med Chem 2004, 12:969-977.
61. Wang SM, Chern JW, Yeh MY, et al. Specific activation of glucuronide prodrugs by antibody-targeted enzyme conjugates for cancer therapy. Cancer Res 1992, 52:4484-4491.
62. Su YC, Chuang KH, Wang YM, et al. Gene expression imaging by enzymatic catalysis of a fluorescent probe via membrane-anchored b-glucuronidase. Gene Ther 2007, 14:565-574.
63. Tzou SC, Roffler S, Chuang KH, et al. Micro-PET imaging of b-glucuronidase activity by the hydrophobic conversion of a glucuronide probe. Radiology 2009, 252:754-762.
64. Gerk PM, Vore M Regulation of expression of the multidrug resistance-associated protein 2 (MRP2) and its role in drug disposition. J Pharmacol Exp Ther 2002, 302:407-415.
65. Ghanem CI, Ruiz ML, Villanueva SS, et al. Shift from biliary to urinary elimination of acetaminophen-glucuronide in acetaminophen-pretreated rats. J Pharmacol Exp Ther 2005, 315:987-995.
66. Horikawa M, Kato Y, Tyson CA, et al. The potential for an interaction between MRP2 (ABCC2) and various therapeutic agents: probenecid as a candidate inhibitor of the biliary excretion of irinotecan metabolites. Drug Metab Pharmacokinet 2002, 17:23-33.
67. Ogasawara T, Takikawa H Biliary excretion of phenolphthalein glucuronide in the rat. Hepatol Res 2001, 20:221-231.
68. Al-Nahhas A, Win Z, Szyszko T, et al. Gallium-68 PET: a new frontier in receptor cancer imaging. Anticancer Res 2007, 27:4087-4094.
69. Cheng TL, Roffler S Membrane-tethered proteins for basic research, imaging, and therapy. Med Res Rev 2008, 28:885-928.
70. Roffler SR, Wang HE, Yu HM, et al. A membrane antibody receptor for noninvasive imaging of gene expression. Gene Ther 2006, 13:412-420.
71. Wei LH, Olafsen T, Radu C, et al. Engineered antibody fragments with infinite affinity as reporter genes for PET imaging. J Nucl Med 2008, 49:1828-1835.
72. Northrop JP, Bednarski M, Barbieri SO, et al. Cell surface expression of single chain antibodies with applications to imaging of gene expression in vivo. Eur J Nucl Med Mol Imaging 2003, 30:1292-1298.
73. Yankell SL, Loux JJ Acute toxicity testing of erythrosine and sodium fluorescein in mice and rats. J Periodontol 1977, 48:228-231.
74. Fu J, Fiegel J, Krauland E, et al. New polymeric carriers for controlled drug delivery following inhalation or injection. Biomaterials 2002, 23:4425-4433.
75. Leiner T, Ho KY, Ho VB, et al. Multicenter phase-II trial of safety and efficacy of NC100150 for steady-state contrast-enhanced peripheral magnetic resonance angiography. Eur Radiol 2003, 13:1620-1627.
76. Ballou B, Lagerholm BC, Ernst LA, et al. Noninvasive imaging of quantum dots in mice. Bioconjug Chem 2004, 15:79-86.
77. Mohs AM, Wang X, Goodrich KC, et al. PEG-g-poly(GdDTPA-co-L-cystine): a biodegradable macromolecular blood pool contrast agent for MR imaging. Bioconjug Chem 2004, 15:1424-1430.